1. Home
  2. FMNB vs DAWN Comparison

FMNB vs DAWN Comparison

Compare FMNB & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmers National Banc Corp.

FMNB

Farmers National Banc Corp.

HOLD

Current Price

$14.03

Market Cap

555.3M

Sector

Finance

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$8.45

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMNB
DAWN
Founded
1887
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.3M
624.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FMNB
DAWN
Price
$14.03
$8.45
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$14.50
$26.56
AVG Volume (30 Days)
174.8K
2.8M
Earning Date
10-22-2025
11-04-2025
Dividend Yield
4.86%
N/A
EPS Growth
17.06
N/A
EPS
1.44
N/A
Revenue
$178,552,000.00
$133,672,000.00
Revenue This Year
$22.69
$15.51
Revenue Next Year
$41.03
$49.99
P/E Ratio
$9.72
N/A
Revenue Growth
9.57
31.11
52 Week Low
$11.58
$5.64
52 Week High
$16.07
$14.46

Technical Indicators

Market Signals
Indicator
FMNB
DAWN
Relative Strength Index (RSI) 64.20 48.23
Support Level $13.51 $8.16
Resistance Level $13.73 $9.72
Average True Range (ATR) 0.30 0.53
MACD 0.12 -0.13
Stochastic Oscillator 94.05 17.45

Price Performance

Historical Comparison
FMNB
DAWN

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: